Cannabigerol (CBG) Market was valued at USD 0.75 Billion in 2022 and is projected to reach USD 3.50 Billion by 2030, growing at a CAGR of 21.5% from 2024 to 2030.
The Cannabigerol (CBG) market is witnessing substantial growth as interest in cannabis-derived products continues to expand. While CBD and THC have long dominated the cannabis conversation, CBG is rapidly gaining recognition for its potential therapeutic benefits and unique properties. Known as the "mother of all cannabinoids," CBG is the precursor to several other cannabinoids, including CBD and THC. This article provides an in-depth analysis of the key trends, growth drivers, challenges, and future outlook for the CBG market.
Cannabigerol (CBG) is a non-psychoactive cannabinoid found in cannabis plants. Unlike THC, which is known for its psychoactive effects, CBG does not produce a "high." It is often referred to as the "precursor cannabinoid" because it is the chemical parent of other cannabinoids such as THC, CBD, CBC, and others. The cannabis plant contains only trace amounts of CBG during the early stages of growth, making it rare and valuable.
CBG has gained significant attention in the wellness and medical industries for its potential therapeutic properties. Early research suggests that CBG may have a variety of benefits, including:
Anti-inflammatory effects: CBG may help reduce inflammation and promote overall health.
Neuroprotective properties: Studies suggest CBG may have potential in treating neurodegenerative diseases like Alzheimer's and Parkinson's.
Antibacterial and antimicrobial effects: CBG has shown promise as a natural antimicrobial agent.
Appetite stimulation: CBG may help stimulate appetite, which is beneficial for patients with conditions like cancer or HIV/AIDS.
Glaucoma treatment: CBG has shown potential for reducing intraocular pressure, making it a possible treatment for glaucoma.
The CBG market is being driven by several factors that are pushing the demand for this cannabinoid in various industries, particularly in wellness, pharmaceuticals, and cosmetics. Some of the most significant drivers include:
The global interest in cannabis and hemp products has surged in recent years, driven by changing perceptions about the cannabis plant and its potential benefits. CBG, being a non-psychoactive cannabinoid, fits into this growing market, particularly among consumers seeking the therapeutic benefits of cannabis without the "high" associated with THC. The increasing acceptance of cannabis products in health and wellness circles has created a favorable market environment for CBG.
The growing body of research into the potential therapeutic applications of CBG is driving market growth. As clinical trials and studies continue to investigate the full range of benefits CBG offers, its use in medical treatments is expected to rise. The cannabinoid’s promise in treating conditions such as anxiety, depression, chronic pain, and neurodegenerative diseases is positioning it as a valuable compound in modern medicine.
The demand for hemp-derived products, such as hemp oils, tinctures, and topicals, has increased significantly as consumers seek out natural alternatives for health and wellness. As part of the broader hemp-based product movement, CBG is gaining traction, especially since it is found in larger quantities in high-CBG strains of hemp, which are now being developed and cultivated more widely.
The gradual legalization of cannabis in several countries and states has expanded the market for cannabinoids, including CBG. As governments introduce more favorable policies surrounding cannabis, manufacturers and consumers are becoming more open to using cannabis-derived products. This trend is expected to continue, providing additional opportunities for growth in the CBG market.
As the cannabis industry matures, there has been an increase in investment in research and development, especially in the study of lesser-known cannabinoids like CBG. Research institutions, pharmaceutical companies, and biotech firms are focusing on understanding the full potential of CBG, which will likely result in the development of new applications and products that could boost demand.
The CBG market can be segmented based on various factors, such as application, distribution channel, and region. These segments present unique opportunities for growth and innovation in the market:
The CBG market can be divided into several key applications, each of which is gaining popularity:
Pharmaceuticals: The medical industry is one of the largest consumers of CBG. Due to its potential therapeutic properties, including anti-inflammatory, neuroprotective, and anti-cancer effects, CBG is being explored for use in pharmaceuticals and medical treatments.
Cosmetics and Personal Care: CBG is gaining traction in the beauty and personal care industry for its potential benefits in skincare products. Due to its anti-inflammatory properties, it is used in lotions, creams, and serums to address skin issues like acne, eczema, and psoriasis.
Food and Beverages: CBG is being incorporated into food and beverage products, such as edibles, drinks, and supplements. Consumers are increasingly looking for functional foods that offer health benefits, and CBG-infused products are gaining popularity for their potential wellness benefits.
Wellness and Supplements: CBG is widely used in the wellness industry, with many companies producing tinctures, capsules, and oils for consumers seeking natural alternatives for stress relief, anxiety reduction, and overall health improvement.
The distribution of CBG products is expanding, with several channels becoming prominent in the market:
Online Retail: E-commerce platforms are growing in popularity as more consumers seek to purchase CBG products from the comfort of their homes. Online retail provides a convenient option for accessing a wide variety of CBG products, from tinctures to cosmetics.
Physical Retail: Traditional retail stores, including pharmacies, health stores, and dispensaries, continue to be important sales channels for CBG products. As consumer awareness increases, more physical retail outlets are offering CBG-infused products.
Direct-to-Consumer (D2C): Many companies are focusing on direct-to-consumer sales models to build stronger relationships with their customer base and offer tailored products. This model allows brands to create a loyal customer base while ensuring higher profit margins.
The demand for CBG products varies significantly across regions, driven by differing regulatory environments, consumer preferences, and market maturity. The key regions in the CBG market include:
North America: North America, particularly the United States, is one of the largest markets for CBG. The increasing legalization of cannabis and the growing acceptance of cannabinoid-based products contribute to the region's dominant market share.
Europe: Europe is also experiencing significant growth in the CBG market as demand for cannabis-derived products rises. Countries like Germany, the Netherlands, and the United Kingdom are at the forefront of adopting cannabis-based wellness products.
Asia Pacific: While cannabis regulations in the Asia Pacific region vary widely, countries like South Korea, Japan, and Thailand are showing increasing interest in cannabis-derived products. The rising popularity of hemp-based products in Asia is expected to drive demand for CBG.
Rest of the World: In other regions, such as Latin America and the Middle East, CBG adoption is still in the early stages. However, as cannabis regulations evolve and consumer awareness grows, the demand for CBG products is expected to rise.
Despite its promising potential, the CBG market faces several challenges that could hinder its growth:
The legal status of cannabis and cannabis-derived products varies widely from country to country, which can create uncertainty for manufacturers and consumers. In some regions, CBG is still considered a controlled substance, making it difficult for companies to market their products. Regulatory hurdles, including the lack of clear labeling standards and the complexity of cannabis regulations, pose challenges for businesses operating in the CBG market.
While early studies into CBG’s therapeutic benefits are promising, there is still a lack of comprehensive clinical data to support the widespread use of CBG in medical treatments. More research is needed to fully understand the cannabinoid’s efficacy and safety, which could limit its adoption in the medical field until more conclusive evidence is available.
CBG is present in cannabis plants in only trace amounts, making its extraction and production more expensive compared to other cannabinoids like CBD. The cost of cultivating high-CBG strains and extracting the cannabinoid is higher, which can drive up the price of CBG-based products. Additionally, supply chain issues, such as the limited availability of high-quality cannabis, can further complicate the market.
Several companies are leading the charge in the CBG market, developing innovative products and driving market growth:
Medical Marijuana, Inc.: A leader in the cannabis industry, Medical Marijuana, Inc. has introduced a range of CBG-infused products, including oils and tinctures.
CW Hemp (Charlotte’s Web): Known for its premium CBD products, CW Hemp is expanding its product range to include CBG-based offerings, leveraging its expertise in hemp cultivation and extraction.
Endoca: Endoca is a prominent producer of hemp-derived CBD and CBG products, offering tinctures, capsules, and topicals for health-conscious consumers.
Bluebird Botanicals: A leading supplier of hemp-based products, Bluebird Botanicals offers CBG oils and tinctures that focus on wellness and therapeutic benefits.
The future of the CBG market looks promising, with continued research, growing consumer demand, and increased investment in cannabis-based products. As more people seek natural and holistic wellness solutions, the demand for CBG products is expected to rise, particularly in the health and wellness, pharmaceutical, and cosmetics sectors.
As legal barriers continue to ease and more research validates the therapeutic benefits of CBG, it is likely to become a mainstream cannabinoid in the wellness and medical industries. Additionally, ongoing developments in extraction technologies and cultivation methods will likely drive down production costs, making CBG products more accessible to consumers and fostering further market growth.
Download Full PDF Sample Copy of Global Cannabigerol (CBG) Report @ https://www.verifiedmarketreports.com/download-sample/?rid=749246&utm_source=Google_site_Feb&utm_medium=229
Hempsana Holdings
Willow Biosciences
Precision Plant Molecules
Bright Green Corporation
Hemptown
Charlotte's Web
Green Road
Demetrix
Canatura
CannaCare
FAB CBD
CBDistillery
Medterra CBD
NuLeaf Naturals
Lazarus Naturals
Avikana
Incr-edibles
Vida Optima
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=749246&utm_source=Google_site_Feb&utm_medium=229
Growing demand for below applications around the world has had a direct impact on the growth of the Global Cannabigerol (CBG) Market
Medicinal
Relieve Stress
Pain Relief
Other
Based on Types the Market is categorized into Below types that held the largest Cannabigerol (CBG) market share In 2023.
Full Spectrum CBG Oil
THC-free CBG Tincture
CBG Isolate
CBG Softgel Capsules
Other
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/cannabigerol-cbg-market/
1. Introduction of the Global Cannabigerol (CBG) Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Cannabigerol (CBG) Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Cannabigerol (CBG) Market, By Type
6. Global Cannabigerol (CBG) Market, By Application
7. Global Cannabigerol (CBG) Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Cannabigerol (CBG) Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/